Molecular genetic studies of ADHD and its candidate genes: A review

Psychiatry Research

Volumn 219, Issue 1, 2014, Pages 10-24

  Li, Zhao ^a,b   Chang, Su hua ^a   Zhang, Liu yan ^a,b   Gao, Lei ^a,b   Wang, Jing ^a  

^a INSTITUTE OF PSYCHOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Association study; Attention deficit hyperactivity disorder; Linkage study; Sample characteristics; Study design

Indexed keywords

ACYL COENZYME A DESATURASE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ARMADILLO DOMAIN PROTEIN; AROMATIC LEVO AMINO ACID DECARBOXYLASE; BRAIN DERIVED NEUROTROPHIC FACTOR; CHOLINERGIC RECEPTOR; CHOLINESTERASE; CILIARY NEUROTROPHIC FACTOR; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE BETA MONOOXYGENASE; DOPAMINE TRANSPORTER; DYNAMIN I; EXCITATORY AMINO ACID TRANSPORTER 1; G PROTEIN COUPLED RECEPTOR; NEURONAL NITRIC OXIDE SYNTHASE; RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR; SEROTONIN; SYNAPTOBREVIN 2; SYNAPTOPHYSIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; SYNAPTOTAGMIN I; SYNTAXIN 1A; TRYPTOPHAN HYDROXYLASE 2; TYROSINE 3 MONOOXYGENASE; UNINDEXED DRUG; VESICULAR MONOAMINE TRANSPORTER 2;

ADRA1B GENE; ADRA2A GENE; ADRA2C GENE; ADRB1 GENE; ADRB2 GENE; ARVCF GENE; ASTN2 GENE; ATP2C2 GENE; ATTENTION DEFICIT DISORDER; BCHE GENE; BDNF GENE; CALY GENE; CCSER1 GENE; CDH13 GENE; CHRNA3 GENE; CHRNA4 GENE; CHRNA7 GENE; CNTF GENE; COMT GENE; CPLX2 GENE; CPLX4 GENE; DBH GENE; DDC GENE; DIRAS2 GENE; DNM1 GENE; DRD1 GENE; DRD2 GENE; DRD3 GENE; DRD4 GENE; DRD5 GENE; EMP2 GENE; FADS2 GENE; FTO GENE; GDNF GENE; GENE; GENE DOSAGE; GENE IDENTIFICATION; GENE INTERACTION; GENE LOCATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GPRC5B GENE; GRIN2A GENE; GRM5 GENE; GRM7 GENE; HES1 GENE; HTR1A GENE; HTR1B GENE; HTR1E GENE; HTR2A GENE; HTR2C GENE; HTR3A GENE; HTR3B GENE; HUMAN; IL20RA GENE; LPHN3 GENE; MAOA GENE; MAOB GENE; MMP7 GENE; MOLECULAR GENETICS; NONHUMAN; NOS1 GENE; PNMT GENE; PRIORITY JOURNAL; PRKG1 GENE; RETROSPECTIVE STUDY; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SLC18A2 GENE; SLC1A3 GENE; SLC6A2 GENE; SLC6A3 GENE; SLC6A4 GENE; SLC9A9 GENE; SNAP25 GENE; SPOCK3 GENE; STX1A GENE; SYP GENE; SYT1 GENE; TCERG1L GENE; TH GENE; TPH1 GENE; TPH2 GENE; TRIO GENE; VAMP2 GENE; COPY NUMBER VARIATION; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETICS; PSYCHOLOGY;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DNA COPY NUMBER VARIATIONS; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; RETROSPECTIVE STUDIES;

EID: 84902551413     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2014.05.005     Document Type: Review

References (165)

1. Adams J., Crosbie J., Wigg K., Ickowicz A., Pathare T., Roberts W., Malone M., Schachar R., Tannock R., Kennedy J.L., Barr C.L. Glutamate receptor, ionotropic, N-methyl d-aspartate 2A (GRIN2A) gene as a positional candidate for attention-deficit/hyperactivity disorder in the 16p13 region. Molecular Psychiatry 2004, 9:494-499.
2. Aerts S., Lambrechts D., Maity S., Van Loo P., Coessens B., De Smet F., Tranchevent L.C., De Moor B., Marynen P., Hassan B., Carmeliet P., Moreau Y. Gene prioritization through genomic data fusion. Nature Biotechnology 2006, 24:537-544.
3. Amin N., Aulchenko Y.S., Dekker M.C., Ferdinand R.F., van Spreeken A., Temmink A.H., Verhulst F.C., Oostra B.A., van Duijn C.M. Suggestive linkage of ADHD to chromosome 18q22 in a young genetically isolated Dutch population. European Journal of Human Genetics: EJHG 2009, 17:958-966.
4. Anney R.J., Lasky-Su J., O'Dushlaine C., Kenny E., Neale B.M., Mulligan A., Franke B., Zhou K., Chen W., Christiansen H., Arias-Vasquez A., Banaschewski T., Buitelaar J., Ebstein R., Miranda A., Mulas F., Oades R.D., Roeyers H., Rothenberger A., Sergeant J., Sonuga-Barke E., Steinhausen H., Asherson P., Faraone S.V., Gill M. Conduct disorder and ADHD: evaluation of conduct problems as a categorical and quantitative trait in the international multicentre ADHD genetics study. American Journal of Medical Genetics. Part B, Neuropsychiatric genEtics: the Official Publication of the International Society of Psychiatric Genetics 2008, 147B:1369-1378.
5. Antshel K.M., Fremont W., Roizen N.J., Shprintzen R., Higgins A.M., Dhamoon A., Kates W.R. ADHD, major depressive disorder, and simple phobias are prevalent psychiatric conditions in youth with velocardiofacial syndrome. Journal of the American Academy of Child and Adolescent Psychiatry 2006, 45:596-603.
6. Arcos-Burgos M., Castellanos F.X., Pineda D., Lopera F., Palacio J.D., Palacio L.G., Rapoport J.L., Berg K., Bailey-Wilson J.E., Muenke M. Attention-deficit/hyperactivity disorder in a population isolate: linkage to loci at 4q13.2, 5q33.3, 11q22, and 17p11. American Journal of Human Genetics 2004, 75:998-1014.
7. Arcos-Burgos M., Jain M., Acosta M.T., Shively S., Stanescu H., Wallis D., Domene S., Velez J.I., Karkera J.D., Balog J., Berg K., Kleta R., Gahl W.A., Roessler E., Long R., Lie J., Pineda D., Londono A.C., Palacio J.D., Arbelaez A., Lopera F., Elia J., Hakonarson H., Johansson S., Knappskog P.M., Haavik J., Ribases M., Cormand B., Bayes M., Casas M., Ramos-Quiroga J.A., Hervas A., Maher B.S., Faraone S.V., Seitz C., Freitag C.M., Palmason H., Meyer J., Romanos M., Walitza S., Hemminger U., Warnke A., Romanos J., Renner T., Jacob C., Lesch K.P., Swanson J., Vortmeyer A., Bailey-Wilson J.E., Castellanos F.X., Muenke M. A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Molecular Psychiatry 2010, 15:1053-1066.
8. Arcos-Burgos M., Jain M., Acosta M.T., Shively S., Stanescu H., Wallis D., Domene S., Velez J.I., Karkera J.D., Balog J., Berg K., Kleta R., Gahl W.A., Roessler E., Long R., Lie J., Pineda D., Londono A.C., Palacio J.D., Arbelaez A., Lopera F., Elia J., Hakonarson H., Johansson S., Knappskog P.M., Haavik J., Ribases M., Cormand B., Bayes M., Casas M., Ramos-Quiroga J.A., Hervas A., Maher B.S., Faraone S.V., Seitz C., Freitag C.M., Palmason H., Meyer J., Romanos M., Walitza S., Hemminger U., Warnke A., Romanos J., Renner T., Jacob C., Lesch K.P., Swanson J., Vortmeyer A., Bailey-Wilson J.E., Castellanos F.X., Muenke M. A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Molecular Psychiatry 2010, 15:1053-1066.
9. Arcos-Burgos M., Muenke M. Toward a better understanding of ADHD: LPHN3 gene variants and the susceptibility to develop ADHD. Attention Deficit and Hyperactivity Disorders 2010, 2:139-147.
10. Asherson P., Zhou K., Anney R.J., Franke B., Buitelaar J., Ebstein R., Gill M., Altink M., Arnold R., Boer F., Brookes K., Buschgens C., Butler L., Cambell D., Chen W., Christiansen H., Feldman L., Fleischman K., Fliers E., Howe-Forbes R., Goldfarb A., Heise A., Gabriels I., Johansson L., Lubetzki I., Marco R., Medad S., Minderaa R., Mulas F., Muller U., Mulligan A., Neale B., Rijsdijk F., Rabin K., Rommelse N., Sethna V., Sorohan J., Uebel H., Psychogiou L., Weeks A., Barrett R., Xu X., Banaschewski T., Sonuga-Barke E., Eisenberg J., Manor I., Miranda A., Oades R.D., Roeyers H., Rothenberger A., Sergeant J., Steinhausen H.C., Taylor E., Thompson M., Faraone S.V. A high-density SNP linkage scan with 142 combined subtype ADHD sib pairs identifies linkage regions on chromosomes 9 and 16. Molecular Psychiatry 2008, 13:514-521.
11. Aureli A., Del Beato T., Sebastiani P., Marimpietri A., Melillo C.V., Sechi E., Di Loreto S. Attention-deficit hyperactivity disorder and intellectual disability: a study of association with brain-derived neurotrophic factor gene polymorphisms. International Journal of Immunopathology and Pharmacology 2010, 23:873-880.
12. Autry A.E., Monteggia L.M. Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacological Reviews 2012, 64:238-258.
13. Ayalew M., Le-Niculescu H., Levey D.F., Jain N., Changala B., Patel S.D., Winiger E., Breier A., Shekhar A., Amdur R., Koller D., Nurnberger J.I., Corvin A., Geyer M., Tsuang M.T., Salomon D., Schork N.J., Fanous A.H., O'Donovan M.C., Niculescu A.B. Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Molecular Psychiatry 2012, 17:887-905.
14. Bakker S.C., van der Meulen E.M., Buitelaar J.K., Sandkuijl L.A., Pauls D.L., Monsuur A.J., van 't Slot R., Minderaa R.B., Gunning W.B., Pearson P.L., Sinke R.J. A whole-genome scan in 164 Dutch sib pairs with attention-deficit/hyperactivity disorder: suggestive evidence for linkage on chromosomes 7p and 15q. American Journal of Human Genetics 2003, 72:1251-1260.
15. Banaschewski T., Becker K., Scherag S., Franke B., Coghill D. Molecular genetics of attention-deficit/hyperactivity disorder: an overview. European Child & Adolescent Psychiatry 2010, 19:237-257.
16. Barkley R.A., Smith K.M., Fischer M., Navia B. An examination of the behavioral and neuropsychological correlates of three ADHD candidate gene polymorphisms (DRD4 7+, DBH TaqI A2, and DAT1 40bp VNTR) in hyperactive and normal children followed to adulthood. American Journal of Medical Genetics. Part B, Neuropsychiatric genetics: The Official Publication of the International Society of Psychiatric Genetics 2006, 141B:487-498.
17. Barr C.L., Feng Y., Wigg K., Bloom S., Roberts W., Malone M., Schachar R., Tannock R., Kennedy J.L. Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention-deficit hyperactivity disorder. Molecular Psychiatry 2000, 5:405-409.
18. Biederman J. Attention-deficit/hyperactivity disorder: a selective overview. Biological Psychiatry 2005, 57:1215-1220.
19. Biederman J., Faraone S., Milberger S., Curtis S., Chen L., Marrs A., Ouellette C., Moore P., Spencer T. Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study. Journal of the American Academy of Child and Adolescent Psychiatry 1996, 35:343-351.
20. Biederman J., Faraone S.V. Attention-deficit hyperactivity disorder. Lancet 2005, 366:237-248.
21. Biederman J., Faraone S.V., Mick E., Spencer T., Wilens T., Kiely K., Guite J., Ablon J.S., Reed E., Warburton R. High risk for attention deficit hyperactivity disorder among children of parents with childhood onset of the disorder: a pilot study. American Journal of Psychiatry 1995, 152:431-435.
22. Biederman J., Faraone S.V., Monuteaux M.C., Bober M., Cadogen E. Gender effects on attention-deficit/hyperactivity disorder in adults, revisited. Biological Psychiatry 2004, 55:692-700.
23. Biederman J., Faraone S.V., Spencer T., Wilens T., Mick E., Lapey K.A. Gender differences in a sample of adults with attention deficit hyperactivity disorder. Psychiatry Research 1994, 53:13-29.
24. Bobb A.J., Castellanos F.X., Addington A.M., Rapoport J.L. Molecular genetic studies of ADHD: 1991 to 2004. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2005, 132B:109-125.
25. Bralten J., Franke B., Waldman I., Rommelse N., Hartman C., Asherson P., Banaschewski T., Ebstein R.P., Gill M., Miranda A., Oades R.D., Roeyers H., Rothenberger A., Sergeant J.A., Oosterlaan J., Sonuga-Barke E., Steinhausen H.C., Faraone S.V., Buitelaar J.K., Arias-Vasquez A. Candidate genetic pathways for attention-deficit/hyperactivity disorder (ADHD) show association to hyperactive/impulsive symptoms in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry 2013, 52(1204-1212):e1201.
26. Brookes K., Xu X., Chen W., Zhou K., Neale B., Lowe N., Anney R., Franke B., Gill M., Ebstein R., Buitelaar J., Sham P., Campbell D., Knight J., Andreou P., Altink M., Arnold R., Boer F., Buschgens C., Butler L., Christiansen H., Feldman L., Fleischman K., Fliers E., Howe-Forbes R., Goldfarb A., Heise A., Gabriels I., Korn-Lubetzki I., Johansson L., Marco R., Medad S., Minderaa R., Mulas F., Muller U., Mulligan A., Rabin K., Rommelse N., Sethna V., Sorohan J., Uebel H., Psychogiou L., Weeks A., Barrett R., Craig I., Banaschewski T., Sonuga-Barke E., Eisenberg J., Kuntsi J., Manor I., McGuffin P., Miranda A., Oades R.D., Plomin R., Roeyers H., Rothenberger A., Sergeant J., Steinhausen H.C., Taylor E., Thompson M., Faraone S.V., Asherson P. The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Molecular Psychiatry 2006, 11:934-953.
27. Brophy K., Hawi Z., Kirley A., Fitzgerald M., Gill M. Synaptosomal-associated protein 25 (SNAP-25) and attention deficit hyperactivity disorder (ADHD): evidence of linkage and association in the Irish population. Molecular Psychiatry 2002, 7:913-917.
28. Chang S., Zhang W., Gao L., Wang J. Prioritization of candidate genes for attention deficit hyperactivity disorder by computational analysis of multiple data sources. Protein & Cell 2012, 3:526-534.
29. Chase T., Carrey N., Soo E., Wilkinson M. Methylphenidate regulates activity regulated cytoskeletal associated but not brain-derived neurotrophic factor gene expression in the developing rat striatum. Neuroscience 2007, 144:969-984.
30. Chen J., Bardes E.E., Aronow B.J., Jegga A.G. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Research 2009, 37:W305-311.
31. Chen Y., Wang W., Zhou Y., Shields R., Chanda S.K., Elston R.C., Li J. In silico gene prioritization by integrating multiple data sources. PloS One 2011, 6:e21137.
32. Chen Y.A., Tripathi L.P., Mizuguchi K. TargetMine, an integrated data warehouse for candidate gene prioritisation and target discovery. PloS One 2011, 6:e17844.
33. Cheuk D.K., Wong V. Meta-analysis of association between a catechol-O-methyltransferase gene polymorphism and attention deficit hyperactivity disorder. Behavior Genetics 2006, 36:651-659.
34. Cho S.C., Kim H.W., Kim B.N., Kim J.W., Shin M.S., Chung S., Cho D.Y., Jung S.W., Yoo H.J., Chung I.W., Chung U.S., Son J.W. Gender-specific association of the brain-derived neurotrophic factor gene with attention-deficit/hyperactivity disorder. Psychiatry Investigation 2010, 7:285-290.
35. Choi T.K., Lee H.S., Kim J.W., Park T.W., Song D.H., Yook K.W., Lee S.H., Kim J.I., Suh S.Y. Support for the MnlI polymorphism of SNAP25; a Korean ADHD case-control study. Molecular Psychiatry 2007, 12:224-226.
36. Chourbaji S., Hellweg R., Brandis D., Zorner B., Zacher C., Lang U.E., Henn F.A., Hortnagl H., Gass P. Mice with reduced brain-derived neurotrophic factor expression show decreased choline acetyltransferase activity, but regular brain monoamine levels and unaltered emotional behavior. Brain Research Molecular Brain Research 2004, 121:28-36.
37. Coghill D., Banaschewski T. The genetics of attention-deficit/hyperactivity disorder. Expert Review of Neurotherapeutics 2009, 9:1547-1565.
38. Contini V., Rovaris D.L., Victor M.M., Grevet E.H., Rohde L.A., Bau C.H. Pharmacogenetics of response to methylphenidate in adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD): a systematic review. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology 2013, 23:555-560.
39. Corradini I., Verderio C., Sala M., Wilson M.C., Matteoli M. SNAP-25 in neuropsychiatric disorders. Annals of the New York Academy of Sciences 2009, 1152:93-99.
40. Cuffe S.P., Moore C.G., McKeown R.E. Prevalence and correlates of ADHD symptoms in the national health interview survey. Journal of Attention Disorders 2005, 9:392-401.
41. Durston S. Imaging genetics in ADHD. NeuroImage 2010, 53:832-838.
42. Elia J., Gai X., Xie H.M., Perin J.C., Geiger E., Glessner J.T., D'Arcy M., deBerardinis R., Frackelton E., Kim C., Lantieri F., Muganga B.M., Wang L., Takeda T., Rappaport E.F., Grant S.F., Berrettini W., Devoto M., Shaikh T.H., Hakonarson H., White P.S. Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Molecular Psychiatry 2010, 15:637-646.
43. Elia J., Glessner J.T., Wang K., Takahashi N., Shtir C.J., Hadley D., Sleiman P.M., Zhang H., Kim C.E., Robison R., Lyon G.J., Flory J.H., Bradfield J.P., Imielinski M., Hou C., Frackelton E.C., Chiavacci R.M., Sakurai T., Rabin C., Middleton F.A., Thomas K.A., Garris M., Mentch F., Freitag C.M., Steinhausen H.C., Todorov A.A., Reif A., Rothenberger A., Franke B., Mick E.O., Roeyers H., Buitelaar J., Lesch K.P., Banaschewski T., Ebstein R.P., Mulas F., Oades R.D., Sergeant J., Sonuga-Barke E., Renner T.J., Romanos M., Romanos J., Warnke A., Walitza S., Meyer J., Palmason H., Seitz C., Loo S.K., Smalley S.L., Biederman J., Kent L., Asherson P., Anney R.J., Gaynor J.W., Shaw P., Devoto M., White P.S., Grant S.F., Buxbaum J.D., Rapoport J.L., Williams N.M., Nelson S.F., Faraone S.V., Hakonarson H. Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nature Genetics 2012, 44:78-84.
44. Fallgatter A.J., Ehlis A.C., Dresler T., Reif A., Jacob C.P., Arcos-Burgos M., Muenke M., Lesch K.P. Influence of a latrophilin 3 (LPHN3) risk haplotype on event-related potential measures of cognitive response control in attention-deficit hyperactivity disorder (ADHD). European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology 2013, 23:458-468.
45. Faraone S., Biederman J., Monuteaux M.C. Further evidence for the diagnostic continuity between child and adolescent ADHD. Journal of Attention Disorders 2002, 6:5-13.
46. Faraone S.V., Biederman J. Neurobiology of attention-deficit hyperactivity disorder. Biological Psychiatry 1998, 44:951-958.
47. Faraone S.V., Doyle A.E., Lasky-Su J., Sklar P.B., D'Angelo E., Gonzalez-Heydrich J., Kratochvil C., Mick E., Klein K., Rezac A.J., Biederman J. Linkage analysis of attention deficit hyperactivity disorder. American journal of medical genetics. Part B. Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics 2008, 147B:1387-1391.
48. Faraone S.V., Perlis R.H., Doyle A.E., Smoller J.W., Goralnick J.J., Holmgren M.A., Sklar P. Molecular genetics of attention-deficit/hyperactivity disorder. Biological Psychiatry 2005, 57:1313-1323.
49. Faraone S.V., Sergeant J., Gillberg C., Biederman J. The worldwide prevalence of ADHD: is it an American condition?. World Psychiatry: Official Journal of the World Psychiatric Association 2003, 2:104-113.
50. Feng Y., Crosbie J., Wigg K., Pathare T., Ickowicz A., Schachar R., Tannock R., Roberts W., Malone M., Swanson J., Kennedy J.L., Barr C.L. The SNAP25 gene as a susceptibility gene contributing to attention-deficit hyperactivity disorder. Molecular Psychiatry 2005, 10(998-1005):1973.
51. Fisher S.E., Francks C., McCracken J.T., McGough J.J., Marlow A.J., MacPhie I.L., Newbury D.F., Crawford L.R., Palmer C.G., Woodward J.A., Del'Homme M., Cantwell D.P., Nelson S.F., Monaco A.P., Smalley S.L. A genomewide scan for loci involved in attention-deficit/hyperactivity disorder. American Journal of Human Genetics 2002, 70:1183-1196.
52. Fliers E.A., Vasquez A.A., Poelmans G., Rommelse N., Altink M., Buschgens C., Asherson P., Banaschewski T., Ebstein R., Gill M., Miranda A., Mulas F., Oades R.D., Roeyers H., Rothenberger A., Sergeant J., Sonuga-Barke E., Steinhausen H.C., Faraone S.V., Buitelaar J.K., Franke B. Genome-wide association study of motor coordination problems in ADHD identifies genes for brain and muscle function. World Journal of Biological Psychiatry: The Official Journal of the World Federation of Societies of Biological Psychiatry 2012, 13:211-222.
53. Forero D.A., Arboleda G.H., Vasquez R., Arboleda H. Candidate genes involved in neural plasticity and the risk for attention-deficit hyperactivity disorder: a meta-analysis of 8 common variants. Journal of Psychiatry & Neuroscience 2009, 34:361-366.
54. Franke B., Faraone S.V., Asherson P., Buitelaar J., Bau C.H., Ramos-Quiroga J.A., Mick E., Grevet E.H., Johansson S., Haavik J., Lesch K.P., Cormand B., Reif A., International Multicentre persistent, A.C The Genetics of Attention Deficit/Hyperactivity Disorder in Adults, a review. Molecular Psychiatry 2012, 17:960-987.
55. Franke B., Hoogman M., Arias Vasquez A., Heister J.G., Savelkoul P.J., Naber M., Scheffer H., Kiemeney L.A., Kan C.C., Kooij J.J., Buitelaar J.K. Association of the dopamine transporter (SLC6A3/DAT1) gene 9-6 haplotype with adult ADHD. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics 2008, 147B:1576-1579.
56. Franke B., Neale B.M., Faraone S.V. Genome-wide association studies in ADHD. Human Genetics 2009, 126:13-50.
57. Franke B., Vasquez A.A., Johansson S., Hoogman M., Romanos J., Boreatti-Hummer A., Heine M., Jacob C.P., Lesch K.P., Casas M., Ribases M., Bosch R., Sanchez-Mora C., Gomez-Barros N., Fernandez-Castillo N., Bayes M., Halmoy A., Halleland H., Landaas E.T., Fasmer O.B., Knappskog P.M., Heister A.J., Kiemeney L.A., Kooij J.J., Boonstra A.M., Kan C.C., Asherson P., Faraone S.V., Buitelaar J.K., Haavik J., Cormand B., Ramos-Quiroga J.A., Reif A. Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2010, 35:656-664.
58. Freimer N., Sabatti C. The use of pedigree, sib-pair and association studies of common diseases for genetic mapping and epidemiology. Nature Genetics 2004, 36:1045-1051.
59. Froehlich T.E., McGough J.J., Stein M.A. Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics. CNS Drugs 2010, 24:99-117.
60. Garner C., McInnes L.A., Service S.K., Spesny M., Fournier E., Leon P., Freimer N.B. Linkage analysis of a complex pedigree with severe bipolar disorder, using a Markov chain Monte Carlo method. American Journal of Human Genetics 2001, 68:1061-1064.
61. Gilman S.R., Chang J., Xu B., Bawa T.S., Gogos J.A., Karayiorgou M., Vitkup D. Diverse types of genetic variation converge on functional gene networks involved in schizophrenia. Nature Neuroscience 2012, 15:1723-1728.
62. Gizer I.R., Ficks C., Waldman I.D. Candidate gene studies of ADHD: a meta-analytic review. Human Genetics 2009, 126:51-90.
63. Guan L., Wang B., Chen Y., Yang L., Li J., Qian Q., Wang Z., Faraone S.V., Wang Y. A high-density single-nucleotide polymorphism screen of 23 candidate genes in attention deficit hyperactivity disorder: suggesting multiple susceptibility genes among Chinese Han population. Molecular Psychiatry 2009, 14:546-554.
64. Haavik J., Halmoy A., Lundervold A.J., Fasmer O.B. Clinical assessment and diagnosis of adults with attention-deficit/hyperactivity disorder. Expert Review of Neurotherapeutics 2010, 10:1569-1580.
65. Hawi Z., Matthews N., Barry E., Kirley A., Wagner J., Wallace R.H., Heussler H.S., Vance A., Gill M., Bellgrove M.A. A high density linkage disequilibrium mapping in 14 noradrenergic genes: evidence of association between SLC6A2, ADRA1B and ADHD. Psychopharmacology 2013, 225:895-902.
66. Hebebrand J., Dempfle A., Saar K., Thiele H., Herpertz-Dahlmann B., Linder M., Kiefl H., Remschmidt H., Hemminger U., Warnke A., Knolker U., Heiser P., Friedel S., Hinney A., Schafer H., Nurnberg P., Konrad K. A genome-wide scan for attention-deficit/hyperactivity disorder in 155 German sib-pairs. Molecular Psychiatry 2006, 11:196-205.
67. Hess E.J., Collins K.A., Wilson M.C. Mouse model of hyperkinesis implicates SNAP-25 in behavioral regulation. Journal of Neuroscience 1996, 16:3104-3111.
68. Hinney A., Scherag A., Jarick I., Albayrak O., Putter C., Pechlivanis S., Dauvermann M.R., Beck S., Weber H., Scherag S., Nguyen T.T., Volckmar A.L., Knoll N., Faraone S.V., Neale B.M., Franke B., Cichon S., Hoffmann P., Nothen M.M., Schreiber S., Jockel K.H., Wichmann H.E., Freitag C., Lempp T., Meyer J., Gilsbach S., Herpertz-Dahlmann B., Sinzig J., Lehmkuhl G., Renner T.J., Warnke A., Romanos M., Lesch K.P., Reif A., Schimmelmann B.G., Hebebrand J., Psychiatric G.C.A.s. Genome-wide association study in German patients with attention deficit/hyperactivity disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2011, 156B:888-897.
69. Jarick I., Volckmar A.L., Putter C., Pechlivanis S., Nguyen T.T., Dauvermann M.R., Beck S., Albayrak O., Scherag S., Gilsbach S., Cichon S., Hoffmann P., Degenhardt F., Nothen M.M., Schreiber S., Wichmann H.E., Jockel K.H., Heinrich J., Tiesler C.M., Faraone S.V., Walitza S., Sinzig J., Freitag C., Meyer J., Herpertz-Dahlmann B., Lehmkuhl G., Renner T.J., Warnke A., Romanos M., Lesch K.P., Reif A., Schimmelmann B.G., Hebebrand J., Scherag A., Hinney A. Genome-wide analysis of rare copy number variations reveals PARK2 as a candidate gene for attention-deficit/hyperactivity disorder. Molecular Psychiatry 2012.
70. Ji H.S., Paik K.C., Park W.S., Lim M.H. No association between the response to methylphenidate and DRD4 gene polymorphism in Korean Attention Deficit Hyperactivity Disorder: a case control study. Clinical Psychopharmacology and Neuroscience: The Official Scientific Journal of the Korean College of Neuropsychopharmacology 2013, 11:13-17.
71. Kalsi G., Whiting P., Bourdelles B.L., Callen D., Barnard E.A., Gurling H. Localization of the human NMDAR2D receptor subunit gene (GRIN2D) to 19q13.1-qter, the NMDAR2A subunit gene to 16p13.2 (GRIN2A), and the NMDAR2C subunit gene (GRIN2C) to 17q24-q25 using somatic cell hybrid and radiation hybrid mapping panels. Genomics 1998, 47:423-425.
72. Kennedy M.J., Ehlers M.D. Mechanisms and function of dendritic exocytosis. Neuron 2011, 69:856-875.
73. Kent L., Green E., Hawi Z., Kirley A., Dudbridge F., Lowe N., Raybould R., Langley K., Bray N., Fitzgerald M., Owen M.J., O'Donovan M.C., Gill M., Thapar A., Craddock N. Association of the paternally transmitted copy of common Valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor (BDNF) gene with susceptibility to ADHD. Molecular Psychiatry 2005, 10:939-943.
74. Kim J.W., Biederman J., Arbeitman L., Fagerness J., Doyle A.E., Petty C., Perlis R.H., Purcell S., Smoller J.W., Faraone S.V., Sklar P. Investigation of variation in SNAP-25 and ADHD and relationship to co-morbid major depressive disorder. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics 2007, 144B:781-790.
75. Kooij J.S., Boonstra A.M., Vermeulen S.H., Heister A.G., Burger H., Buitelaar J.K., Franke B. Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1). American journal of Medical Genetics. Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics 2008, 147B:201-208.
76. Kuntsi J., Stevenson J. Hyperactivity in children: a focus on genetic research and psychological theories. Clinical Child and Family Psychology Review 2000, 3:1-23.
77. Kustanovich V., Merriman B., McGough J., McCracken J.T., Smalley S.L., Nelson S.F. Biased paternal transmission of SNAP-25 risk alleles in attention-deficit hyperactivity disorder. Molecular Psychiatry 2003, 8:309-315.
78. Laird N.M., Lange C. Family-based designs in the age of large-scale gene-association studies. Nature Reviews. Genetics 2006, 7:385-394.
79. Landaas E.T., Johansson S., Jacobsen K.K., Ribases M., Bosch R., Sanchez-Mora C., Jacob C.P., Boreatti-Hummer A., Kreiker S., Lesch K.P., Kiemeney L.A., Kooij J.J., Kan C., Buitelaar J.K., Faraone S.V., Halmoy A., Ramos-Quiroga J.A., Cormand B., Reif A., Franke B., Mick E., Knappskog P.M., Haavik J. An international multicenter association study of the serotonin transporter gene in persistent ADHD. Genes, Brain, and Behavior 2010, 9:449-458.
80. Lanktree M., Squassina A., Krinsky M., Strauss J., Jain U., Macciardi F., Kennedy J.L., Muglia P. Association study of brain-derived neurotrophic factor (BDNF) and LIN-7 homolog (LIN-7) genes with adult attention-deficit/hyperactivity disorder. American Journal of Medical genetics. Part B,Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics 2008, 147B:945-951.
81. Lasky-Su J., Anney R.J., Neale B.M., Franke B., Zhou K., Maller J.B., Vasquez A.A., Chen W., Asherson P., Buitelaar J., Banaschewski T., Ebstein R., Gill M., Miranda A., Mulas F., Oades R.D., Roeyers H., Rothenberger A., Sergeant J., Sonuga-Barke E., Steinhausen H.C., Taylor E., Daly M., Laird N., Lange C., Faraone S.V. Genome-wide association scan of the time to onset of attention deficit hyperactivity disorder. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics 2008, 147B:1355-1358.
82. Lasky-Su J., Neale B.M., Franke B., Anney R.J., Zhou K., Maller J.B., Vasquez A.A., Chen W., Asherson P., Buitelaar J., Banaschewski T., Ebstein R., Gill M., Miranda A., Mulas F., Oades R.D., Roeyers H., Rothenberger A., Sergeant J., Sonuga-Barke E., Steinhausen H.C., Taylor E., Daly M., Laird N., Lange C., Faraone S.V. Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2008, 147B:1345-1354.
83. Lee J., Laurin N., Crosbie J., Ickowicz A., Pathare T., Malone M., Tannock R., Kennedy J.L., Schachar R., Barr C.L. Association study of the brain-derived neurotropic factor (BDNF) gene in attention deficit hyperactivity disorder. American journal of Medical Genetics. Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics 2007, 144B:976-981.
84. Lee S.W. H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nature Medicine 1996, 2:776-782.
85. Lesch K.P., Selch S., Renner T.J., Jacob C., Nguyen T.T., Hahn T., Romanos M., Walitza S., Shoichet S., Dempfle A., Heine M., Boreatti-Hummer A., Romanos J., Gross-Lesch S., Zerlaut H., Wultsch T., Heinzel S., Fassnacht M., Fallgatter A., Allolio B., Schafer H., Warnke A., Reif A., Ropers H.H., Ullmann R. Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree. Molecular Psychiatry 2011, 16:491-503.
86. Lesch K.P., Timmesfeld N., Renner T.J., Halperin R., Roser C., Nguyen T.T., Craig D.W., Romanos J., Heine M., Meyer J., Freitag C., Warnke A., Romanos M., Schafer H., Walitza S., Reif A., Stephan D.A., Jacob C. Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. Journal of Neural Transmission 2008, 115:1573-1585.
87. Li D., Sham P.C., Owen M.J., He L. Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Human Molecular Genetics 2006, 15:2276-2284.
88. Li M., Luo X.J., Rietschel M., Lewis C.M., Mattheisen M., Muller-Myhsok B., Jamain S., Leboyer M., Landen M., Thompson P.M., Cichon S., Nothen M.M., Schulze T.G., Sullivan P.F., Bergen S.E., Donohoe G., Morris D.W., Hargreaves A., Gill M., Corvin A., Hultman C., Toga A.W., Shi L., Lin Q., Shi H., Gan L., Meyer-Lindenberg A., Czamara D., Henry C., Etain B., Bis J.C., Ikram M.A., Fornage M., Debette S., Launer L.J., Seshadri S., Erk S., Walter H., Heinz A., Bellivier F., Stein J.L., Medland S.E., Vasquez A.A., Hibar D.P., Franke B., Martin N.G., Wright M.J. Allelic differences between Europeans and Chinese for CREB1 SNPs and their implications in gene expression regulation, hippocampal structure and function, and bipolar disorder susceptibility. Molecular Psychiatry 2013.
89. Lionel A.C., Crosbie J., Barbosa N., Goodale T., Thiruvahindrapuram B., Rickaby J., Gazzellone M., Carson A.R., Howe J.L., Wang Z., Wei J., Stewart A.F., Roberts R., McPherson R., Fiebig A., Franke A., Schreiber S., Zwaigenbaum L., Fernandez B.A., Roberts W., Arnold P.D., Szatmari P., Marshall C.R., Schachar R., Scherer S.W. Rare copy number variation discovery and cross-disorder comparisons identify risk genes for ADHD. Science Translational Medicine. 95ra75 2011, 3.
90. Lyon G.J., Jiang T., Van Wijk R., Wang W., Bodily P.M., Xing J., Tian L., Robison R.J., Clement M., Lin Y., Zhang P., Liu Y., Moore B., Glessner J.T., Elia J., Reimherr F., van Solinge W.W., Yandell M., Hakonarson H., Wang J., Johnson W.E., Wei Z., Wang K. Exome sequencing and unrelated findings in the context of complex disease research: ethical and clinical implications. Discovery Medicine 2011, 12:41-55.
91. Maher B.S., Marazita M.L., Ferrell R.E., Vanyukov M.M. Dopamine system genes and attention deficit hyperactivity disorder: a meta-analysis. Psychiatric Genetics 2002, 12:207-215.
92. Malhotra D., Sebat J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell 2012, 148:1223-1241.
93. Mattay V.S., Goldberg T.E., Fera F., Hariri A.R., Tessitore A., Egan M.F., Kolachana B., Callicott J.H., Weinberger D.R. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:6186-6191.
94. Mavroconstanti T., Johansson S., Winge I., Knappskog P.M., Haavik J. Functional properties of rare missense variants of human CDH13 found in adult attention deficit/hyperactivity disorder (ADHD) patients. PLoS One 2013, 8:e71445.
95. McGough J., McCracken J., Swanson J., Riddle M., Kollins S., Greenhill L., Abikoff H., Davies M., Chuang S., Wigal T., Wigal S., Posner K., Skrobala A., Kastelic E., Ghuman J., Cunningham C., Shigawa S., Moyzis R., Vitiello B. Pharmacogenetics of methylphenidate response in preschoolers with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry 2006, 45:1314-1322.
96. Meredith G.E., Callen S., Scheuer D.A. Brain-derived neurotrophic factor expression is increased in the rat amygdala, piriform cortex and hypothalamus following repeated amphetamine administration. Brain Research 2002, 949:218-227.
97. Michaelovsky E., Gothelf D., Korostishevsky M., Frisch A., Burg M., Carmel M., Steinberg T., Inbar D., Apter A., Weizman A. Association between a common haplotype in the COMT gene region and psychiatric disorders in individuals with 22q11.2DS. International Journal of Neuropsychopharmacology/Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum 2008, 11:351-363.
98. Mick E., McGough J., Loo S., Doyle A.E., Wozniak J., Wilens T.E., Smalley S., McCracken J., Biederman J., Faraone S.V. Genome-wide association study of the child behavior checklist dysregulation profile. Journal of the American Academy of Child and Adolescent Psychiatry 2011, 50(807-817):e808.
99. Mick E., Neale B., Middleton F.A., McGough J.J., Faraone S.V. Genome-wide association study of response to methylphenidate in 187 children with attention-deficit/hyperactivity disorder. American journal of medical genetics. Part B. Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics 2008, 147B:1412-1418.
100. Mick E., Todorov A., Smalley S., Hu X., Loo S., Todd R.D., Biederman J., Byrne D., Dechairo B., Guiney A., McCracken J., McGough J., Nelson S.F., Reiersen A.M., Wilens T.E., Wozniak J., Neale B.M., Faraone S.V. Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2010, 49(898-905):e893.
101. Mill J., Curran S., Kent L., Gould A., Huckett L., Richards S., Taylor E., Asherson P. Association study of a SNAP-25 microsatellite and attention deficit hyperactivity disorder. American Journal of Medical Genetics 2002, 114:269-271.
102. Mill J., Richards S., Knight J., Curran S., Taylor E., Asherson P. Haplotype analysis of SNAP-25 suggests a role in the aetiology of ADHD. Molecular Psychiatry 2004, 9:801-810.
103. Neale B.M., Lasky-Su J., Anney R., Franke B., Zhou K., Maller J.B., Vasquez A.A., Asherson P., Chen W., Banaschewski T., Buitelaar J., Ebstein R., Gill M., Miranda A., Oades R.D., Roeyers H., Rothenberger A., Sergeant J., Steinhausen H.C., Sonuga-Barke E., Mulas F., Taylor E., Laird N., Lange C., Daly M., Faraone S.V. Genome-wide association scan of attention deficit hyperactivity disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2008, 147B:1337-1344.
104. Neale B.M., Medland S., Ripke S., Anney R.J., Asherson P., Buitelaar J., Franke B., Gill M., Kent L., Holmans P., Middleton F., Thapar A., Lesch K.P., Faraone S.V., Daly M., Nguyen T.T., Schafer H., Steinhausen H.C., Reif A., Renner T.J., Romanos M., Romanos J., Warnke A., Walitza S., Freitag C., Meyer J., Palmason H., Rothenberger A., Hawi Z., Sergeant J., Roeyers H., Mick E., Biederman J., Group I.I.C. Case-control genome-wide association study of attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2010, 49:906-920.
105. Neale B.M., Medland S.E., Ripke S., Asherson P., Franke B., Lesch K.P., Faraone S.V., Nguyen T.T., Schafer H., Holmans P., Daly M., Steinhausen H.C., Freitag C., Reif A., Renner T.J., Romanos M., Romanos J., Walitza S., Warnke A., Meyer J., Palmason H., Buitelaar J., Vasquez A.A., Lambregts-Rommelse N., Gill M., Anney R.J., Langely K., O'Donovan M., Williams N., Owen M., Thapar A., Kent L., Sergeant J., Roeyers H., Mick E., Biederman J., Doyle A., Smalley S., Loo S., Hakonarson H., Elia J., Todorov A., Miranda A., Mulas F., Ebstein R.P., Rothenberger A., Banaschewski T., Oades R.D., Sonuga-Barke E., McGough J., Nisenbaum L., Middleton F., Hu X., Nelson S., Psychiatric G.C.A.S. Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2010, 49:884-897.
106. NIH National Institutes of Health Consensus Development Conference Statement: diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD). American Academy of Child and Adolescent Psychiatry 2000, 39:182-193.
107. Nikolaidis A., Gray J.R. ADHD and the DRD4 exon III 7-repeat polymorphism: an international meta-analysis. Social Cognitive and Affective Neuroscience 2010, 5:188-193.
108. Nyman E.S., Ogdie M.N., Loukola A., Varilo T., Taanila A., Hurtig T., Moilanen I.K., Loo S.K., McGough J.J., Jarvelin M.R., Smalley S.L., Nelson S.F., Peltonen L. ADHD candidate gene study in a population-based birth cohort: association with DBH and DRD2. Journal of the American Academy of Child and Adolescent Psychiatry 2007, 46:1614-1621.
109. Oades R.D., Lasky-Su J., Christiansen H., Faraone S.V., Sonuga-Barke E.J., Banaschewski T., Chen W., Anney R.J., Buitelaar J.K., Ebstein R.P., Franke B., Gill M., Miranda A., Roeyers H., Rothenberger A., Sergeant J.A., Steinhausen H.C., Taylor E.A., Thompson M., Asherson P. The influence of serotonin- and other genes on impulsive behavioral aggression and cognitive impulsivity in children with attention-deficit/hyperactivity disorder (ADHD): Findings from a family-based association test (FBAT) analysis. Behavioral and Brain Functions 2008, 4:48.
110. Ogdie M.N., Bakker S.C., Fisher S.E., Francks C., Yang M.H., Cantor R.M., Loo S.K., van der Meulen E., Pearson P., Buitelaar J., Monaco A., Nelson S.F., Sinke R.J., Smalley S.L. Pooled genome-wide linkage data on 424 ADHD ASPs suggests genetic heterogeneity and a common risk locus at 5p13. Molecular Psychiatry 2006, 11:5-8.
111. Ogdie M.N., Fisher S.E., Yang M., Ishii J., Francks C., Loo S.K., Cantor R.M., McCracken J.T., McGough J.J., Smalley S.L., Nelson S.F. Attention deficit hyperactivity disorder: fine mapping supports linkage to 5p13, 6q12, 16p13, and 17p11. American Journal of Human Genetics 2004, 75:661-668.
112. Ogdie M.N., Macphie I.L., Minassian S.L., Yang M., Fisher S.E., Francks C., Cantor R.M., McCracken J.T., McGough J.J., Nelson S.F., Monaco A.P., Smalley S.L. A genomewide scan for attention-deficit/hyperactivity disorder in an extended sample: suggestive linkage on 17p11. American Journal of Human Genetics 2003, 72:1268-1279.
113. Palmason H., Moser D., Sigmund J., Vogler C., Hanig S., Schneider A., Seitz C., Marcus A., Meyer J., Freitag C.M. Attention-deficit/hyperactivity disorder phenotype is influenced by a functional catechol-O-methyltransferase variant. Journal of Neural Transmission 2010, 117:259-267.
114. Park S., Jung S.W., Kim B.N., Cho S.C., Shin M.S., Kim J.W., Yoo H.J., Cho D.Y., Chung U.S., Son J.W., Kim H.W. Association between the GRM7 rs3792452 polymorphism and attention deficit hyperacitiveity disorder in a Korean sample. Behavioral and Brain Functions 2013, 9:1.
115. Perez-Lezaun A., Calafell F., Mateu E., Comas D., Bosch E., Bertranpetit J. Allele frequencies for 20 microsatellites in a worldwide population survey. Human Heredity 1997, 47:189-196.
116. Poelmans G., Pauls D.L., Buitelaar J.K., Franke B. Integrated genome-wide association study findings: identification of a neurodevelopmental network for Attention Deficit Hyperactivity Disorder. American Journal of Psychiatry 2011, 168:365-377.
117. Polanczyk G., Bigarella M.P., Hutz M.H., Rohde L.A. Pharmacogenetic approach for a better drug treatment in children. Current Pharmaceutical Design 2010, 16:2462-2473.
118. Polanczyk G., de Lima M.S., Horta B.L., Biederman J., Rohde L.A. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. American Journal of Psychiatry 2007, 164:942-948.
119. Polanczyk G., Zeni C., Genro J.P., Guimaraes A.P., Roman T., Hutz M.H., Rohde L.A. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder. Archives of General Psychiatry 2007, 64:218-224.
120. Price A.L., Patterson N.J., Plenge R.M., Weinblatt M.E., Shadick N.A., Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nature Genetics 2006, 38:904-909.
121. Qian Q., Wang Y., Li J., Yang L., Wang B., Zhou R., Glatt S.J., Faraone S.V. Evaluation of potential gene-gene interactions for attention deficit hyperactivity disorder in the Han Chinese population. American journal of medical genetics. Part B. Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics 2007, 144B:200-206.
122. Race E., Genetics Working G. The use of racial, ethnic, and ancestral categories in human genetics research. American Journal of Human Genetics 2005, 77:519-532.
123. Ramos-Quiroga J.A., Sanchez-Mora C., Casas M., Garcia-Martinez I., Bosch R., Nogueira M., Corrales M., Palomar G., Vidal R., Coll-Tane M., Bayes M., Cormand B., Ribases M. Genome-wide copy number variation analysis in adult attention-deficit and hyperactivity disorder. Journal of Psychiatric Research 2014, 49:60-67.
124. Redpath H.L., Lawrie S.M., Sprooten E., Whalley H.C., McIntosh A.M., Hall J. Progress in imaging the effects of psychosis susceptibility gene variants. Expert Review of Neurotherapeutics 2013, 13:37-47.
125. Rhee S.H., Waldman I.D., Hay D.A., Levy F. Sex differences in genetic and environmental influences on DSM-III-R attention-deficit/hyperactivity disorder. Journal of Abnormal Psychology 1999, 108:24-41.
126. Ribases M., Bosch R., Hervas A., Ramos-Quiroga J.A., Sanchez-Mora C., Bielsa A., Gastaminza X., Guijarro-Domingo S., Nogueira M., Gomez-Barros N., Kreiker S., Gross-Lesch S., Jacob C.P., Lesch K.P., Reif A., Johansson S., Plessen K.J., Knappskog P.M., Haavik J., Estivill X., Casas M., Bayes M., Cormand B. Case-control study of six genes asymmetrically expressed in the two cerebral hemispheres: association of BAIAP2 with attention-deficit/hyperactivity disorder. Biological Psychiatry 2009, 66:926-934.
127. Ribases M., Hervas A., Ramos-Quiroga J.A., Bosch R., Bielsa A., Gastaminza X., Fernandez-Anguiano M., Nogueira M., Gomez-Barros N., Valero S., Gratacos M., Estivill X., Casas M., Cormand B., Bayes M. Association study of 10 genes encoding neurotrophic factors and their receptors in adult and child attention-deficit/hyperactivity disorder. Biological Psychiatry 2008, 63:935-945.
128. Ribases M., Ramos-Quiroga J.A., Hervas A., Bosch R., Bielsa A., Gastaminza X., Artigas J., Rodriguez-Ben S., Estivill X., Casas M., Cormand B., Bayes M. Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB. Molecular Psychiatry 2009, 14:71-85.
129. Ribases M., Ramos-Quiroga J.A., Hervas A., Sanchez-Mora C., Bosch R., Bielsa A., Gastaminza X., Lesch K.P., Reif A., Renner T.J., Romanos M., Warnke A., Walitza S., Freitag C., Meyer J., Palmason H., Casas M., Bayes M., Cormand B. Candidate system analysis in ADHD: evaluation of nine genes involved in dopaminergic neurotransmission identifies association with DRD1. World Journal of Biological Psychiatry: The Official Journal of the World Federation of Societies of Biological Psychiatry 2012, 13:281-292.
130. Ribases M., Ramos-Quiroga J.A., Sanchez-Mora C., Bosch R., Richarte V., Palomar G., Gastaminza X., Bielsa A., Arcos-Burgos M., Muenke M., Castellanos F.X., Cormand B., Bayes M., Casas M. Contribution of LPHN3 to the genetic susceptibility to ADHD in adulthood: a replication study. Genes, Brain, and Behavior 2011, 10:149-157.
131. Ripke S., Sanders A.R., Kendler K.S., Levinson D.F., Sklar P., Holmans P.A., Lin D.Y., Duan J., Ophoff R.A., Andreassen O.A., Scolnick E., Cichon S., Clair D., Corvin A., Gurling H., Werge T., Rujescu D., Blackwood D.H., Pato C.N., Malhotra A.K., Purcell S., Dudbridge F., Neale B.M., Rossin L., Visscher P.M., Posthuma D., Ruderfer D.M., Fanous A., Stefansson H., Steinberg S., Mowry B.J., Golimbet V., De Hert M., Jonsson E.G., Bitter I., Pietilainen O.P., Collier D.A., Tosato S., Agartz I., Albus M., Alexander M., Amdur R.L., Amin F., Bass N., Bergen S.E., Black D.W., Borglum A.D., Brown M.A., Bruggeman R., Buccola N.G., Byerley W.F., Cahn W., Cantor R.M., Carr V.J., Catts S.V., Choudhury K., Cloninger C.R., Cormican P., Craddock N., Danoy P.A., Datta S., de Haan L., Demontis D., Dikeos D., Djurovic S., Donnelly P., Donohoe G., Duong L., Dwyer S., Fink-Jensen A., Freedman R., Freimer N.B., Friedl M., Georgieva L., Giegling I., Gill M., Glenthoj B., Godard S., Hamshere M., Hansen M., Hansen T., Hartmann A.M., Henskens F.A., Hougaard D.M., Hultman C.M., Ingason A., Jablensky A.V., Jakobsen K.D., Jay M., Jurgens G., Kahn R.S., Keller M.C., Kenis G., Kenny E., Kim Y., Kirov G.K., Konnerth H., Konte B., Krabbendam L., Krasucki R., Lasseter V.K., Laurent C., Lawrence J., Lencz T., Lerer F.B., Liang K.Y., Lichtenstein P., Lieberman J.A., Linszen D.H., Lonnqvist J., Loughland C.M., Maclean A.W., Maher B.S., Maier W., Mallet J., Malloy P., Mattheisen M., Mattingsdal M., McGhee K.A., McGrath J.J., McIntosh A., McLean D.E., McQuillin A., Melle I., Michie P.T., Milanova V., Morris D.W., Mors O., Mortensen P.B., Moskvina V., Muglia P., Myin-Germeys I., Nertney D.A., Nestadt G., Nielsen J., Nikolov I., Nordentoft M., Norton N., Nothen M.M., O'Dushlaine C.T., Olincy A., Olsen L., O'Neill F.A., Orntoft T.F., Owen M.J., Pantelis C., Papadimitriou G., Pato M.T., Peltonen L., Petursson H., Pickard B., Pimm J., Pulver A.E., Puri V., Quested D., Quinn E.M., Rasmussen H.B., Rethelyi J.M., Ribble R., Rietschel M., Riley B.P., Ruggeri M., Schall U., Schulze T.G., Schwab S.G., Scott R.J., Shi J., Sigurdsson E., Silverman J.M., Spencer C.C., Stefansson K., Strange A., Strengman E., Stroup T.S., Suvisaari J., Terenius L., Thirumalai S., Thygesen J.H., Timm S., Toncheva D., van den Oord E., van Os J., van Winkel R., Veldink J., Walsh D., Wang A.G., Wiersma D., Wildenauer D.B., Williams H.J., Williams N.M., Wormley B., Zammit S., Sullivan P.F., O'Donovan M.C., Daly M.J., Gejman P.V., Schizophrenia Psychiatric Genome-Wide Association Study C. Genome-wide association study identifies five new schizophrenia loci. Nature Genetics 2011, 43:969-976.
132. Romanos M., Freitag C., Jacob C., Craig D.W., Dempfle A., Nguyen T.T., Halperin R., Walitza S., Renner T.J., Seitz C., Romanos J., Palmason H., Reif A., Heine M., Windemuth-Kieselbach C., Vogler C., Sigmund J., Warnke A., Schafer H., Meyer J., Stephan D.A., Lesch K.P. Genome-wide linkage analysis of ADHD using high-density SNP arrays: novel loci at 5q13.1 and 14q12. Molecular Psychiatry 2008, 13:522-530.
133. Rommelse N.N., Arias-Vasquez A., Altink M.E., Buschgens C.J., Fliers E., Asherson P., Faraone S.V., Buitelaar J.K., Sergeant J.A., Oosterlaan J., Franke B. Neuropsychological endophenotype approach to genome-wide linkage analysis identifies susceptibility loci for ADHD on 2q21.1 and 13q12.11. American Journal of Human Genetics 2008, 83:99-105.
134. Sanchez-Mora C., Cormand B., Ramos-Quiroga J.A., Hervas A., Bosch R., Palomar G., Nogueira M., Gomez-Barros N., Richarte V., Corrales M., Garcia-Martinez I., Corominas R., Guijarro S., Bigorra A., Bayes M., Casas M., Ribases M. Evaluation of common variants in 16 genes involved in the regulation of neurotransmitter release in ADHD. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology 2013, 23:426-435.
135. Sanchez-Mora C., Ramos-Quiroga J.A., Garcia-Martinez I., Fernandez-Castillo N., Bosch R., Richarte V., Palomar G., Nogueira M., Corrales M., Daigre C., Martinez-Luna N., Grau-Lopez L., Toma C., Cormand B., Roncero C., Casas M., Ribases M. Evaluation of single nucleotide polymorphisms in the miR-183-96-182 cluster in adulthood attention-deficit and hyperactivity disorder (ADHD) and substance use disorders (SUDs). European neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology 2013, 23:1463-1473.
136. Sanchez-Mora C., Ribases M., Casas M., Bayes M., Bosch R., Fernandez-Castillo N., Brunso L., Jacobsen K.K., Landaas E.T., Lundervold A.J., Gross-Lesch S., Kreiker S., Jacob C.P., Lesch K.P., Buitelaar J.K., Hoogman M., Kiemeney L.A., Kooij J.J., Mick E., Asherson P., Faraone S.V., Franke B., Reif A., Johansson S., Haavik J., Ramos-Quiroga J.A., Cormand B. Exploring DRD4 and its interaction with SLC6A3 as possible risk factors for adult ADHD: a meta-analysis in four European populations. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics 2011, 156B:600-612.
137. Sanchez-Mora C., Ribases M., Ramos-Quiroga J.A., Casas M., Bosch R., Boreatti-Hummer A., Heine M., Jacob C.P., Lesch K.P., Fasmer O.B., Knappskog P.M., Kooij J.J., Kan C., Buitelaar J.K., Mick E., Asherson P., Faraone S.V., Franke B., Johansson S., Haavik J., Reif A., Bayes M., Cormand B. Meta-analysis of brain-derived neurotrophic factor p.Val66Met in adult ADHD in four European populations. American journal of Medical Genetics. Part B, Neuropsychiatric genetics: The Official Publication of the International Society of Psychiatric Genetics 2010, 153B:512-523.
138. Sarkar K., Bhaduri N., Ghosh P., Sinha S., Ray A., Chatterjee A., Mukhopadhyay K. Role of SNAP25 explored in eastern Indian attention deficit hyperactivity disorder probands. Neurochemical Research 2012, 37:349-357.
139. Saviouk V., Hottenga J.J., Slagboom E.P., Distel M.A., de Geus E.J., Willemsen G., Boomsma D.I. ADHD in Dutch adults: heritability and linkage study. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: the Official Publication of the International Society of Psychiatric Genetics 2011, 156B:352-362.
140. Sharp S.I., McQuillin A., Gurling H.M. Genetics of attention-deficit hyperactivity disorder (ADHD). Neuropharmacology 2009, 57:590-600.
141. Shaw D.M., Blazek R., Tidmarsh S.F., Riley G.J., Johnson A.L., Michalakeas A. Distribution of tryptophan and tyrosine in unipolar affective disorders as defined by multicompartmental analysis. Journal of Neural Transmission. Supplementa 1979, 15:197-207.
142. Smalley S.L., Kustanovich V., Minassian S.L., Stone J.L., Ogdie M.N., McGough J.J., McCracken J.T., MacPhie I.L., Francks C., Fisher S.E., Cantor R.M., Monaco A.P., Nelson S.F. Genetic linkage of attention-deficit/hyperactivity disorder on chromosome 16p13, in a region implicated in autism. American Journal of Human Genetics 2002, 71:959-963.
143. Smith T.F. Meta-analysis of the heterogeneity in association of DRD4 7-repeat allele and AD/HD: stronger association with AD/HD combined type. American journal of Medical Genetics. Part B, Neuropsychiatric Genetics: the Official Publication of the International Society of Psychiatric Genetics 2010, 153B:1189-1199.
144. Sollner T., Whiteheart S.W., Brunner M., Erdjument-Bromage H., Geromanos S., Tempst P., Rothman J.E. SNAP receptors implicated in vesicle targeting and fusion. Nature 1993, 362:318-324.
145. Spencer C.C., Su Z., Donnelly P., Marchini J. Designing genome-wide association studies: sample size, power, imputation, and the choice of genotyping chip. PLoS Genetics 2009, 5:e1000477.
146. Stergiakouli E., Hamshere M., Holmans P., Langley K., Zaharieva I., de C.G., Psychiatric G.C., Hawi Z., Kent L., Gill M., Williams N., Owen M.J., O'Donovan M., Thapar A. Investigating the contribution of common genetic variants to the risk and pathogenesis of ADHD. American Journal of Psychiatry 2012, 169:186-194.
147. Stergiakouli E., Hamshere M., Holmans P., Langley K., Zaharieva I., Hawi Z., Kent L., Gill M., Williams N., Owen M.J., O'Donovan M., Thapar A. Investigating the contribution of common genetic variants to the risk and pathogenesis of ADHD. American Journal of Psychiatry 2012, 169:186-194.
148. Stergiakouli E., Thapar A. Fitting the pieces together: current research on the genetic basis of attention-deficit/hyperactivity disorder (ADHD). Neuropsychiatric Disease and Treatment 2010, 6:551-560.
149. Tahir E., Yazgan Y., Cirakoglu B., Ozbay F., Waldman I., Asherson P.J. Association and linkage of DRD4 and DRD5 with attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children. Molecular Psychiatry 2000, 5:396-404.
150. Thakur G.A., Sengupta S.M., Grizenko N., Choudhry Z., Joober R. Family-based association study of ADHD and genes increasing the risk for smoking behaviours. Archives of Disease in Childhood 2012, 97:1027-1033.
151. Thapar A., Cooper M., Eyre O., Langley K. What have we learnt about the causes of ADHD?. Journal of child Psychology and Psychiatry, and Allied Disciplines 2013, 54:3-16.
152. Tranchevent L.-C., Capdevila F.B., Nitsch D., De Moor B., De Causmaecker P., Moreau Y. A guide to web tools to prioritize candidate genes. Briefings in Bioinformatics 2010, 12:22-32.
153. Tranchevent L.C., Barriot R., Yu S., Van Vooren S., Van Loo P., Coessens B., De Moor B., Aerts S., Moreau Y. ENDEAVOUR update: a web resource for gene prioritization in multiple species. Nucleic Acids Research 2008, 36:W377-W384.
154. Tripp G., Wickens J.R. Neurobiology of ADHD. Neuropharmacology 2009, 57:579-589.
155. Turic D., Langley K., Mills S., Stephens M., Lawson D., Govan C., Williams N., Van Den Bree M., Craddock N., Kent L., Owen M., O'Donovan M., Thapar A. Follow-up of genetic linkage findings on chromosome 16p13: evidence of association of N-methyl-d aspartate glutamate receptor 2A gene polymorphism with ADHD. Molecular Psychiatry 2004, 9:169-173.
156. Vegt R., Bertoli-Avella A.M., Tulen J.H., de Graaf B., Verkerk A.J., Vervoort J., Twigt C.M., Maat-Kievit A., vanTuijl R., van der Lijn M., Hengeveld M.W., Oostra B.A. Genome-wide linkage analysis in a Dutch multigenerational family with attention deficit hyperactivity disorder. European Journal of Human Genetics: EJHG 2010, 18:206-211.
157. Wallis D., Hill D.S., Mendez I.A., Abbott L.C., Finnell R.H., Wellman P.J., Setlow B. Initial characterization of mice null for Lphn3, a gene implicated in ADHD and addiction. Brain Research 2012, 1463:85-92.
158. Williams N.M., Franke B., Mick E., Anney R.J., Freitag C.M., Gill M., Thapar A., O'Donovan M.C., Owen M.J., Holmans P., Kent L., Middleton F., Zhang-James Y., Liu L., Meyer J., Nguyen T.T., Romanos J., Romanos M., Seitz C., Renner T.J., Walitza S., Warnke A., Palmason H., Buitelaar J., Rommelse N., Vasquez A.A., Hawi Z., Langley K., Sergeant J., Steinhausen H.C., Roeyers H., Biederman J., Zaharieva I., Hakonarson H., Elia J., Lionel A.C., Crosbie J., Marshall C.R., Schachar R., Scherer S.W., Todorov A., Smalley S.L., Loo S., Nelson S., Shtir C., Asherson P., Reif A., Lesch K.P., Faraone S.V. Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3. American Journal of Psychiatry 2012, 169:195-204.
159. Williams N.M., Zaharieva I., Martin A., Langley K., Mantripragada K., Fossdal R., Stefansson H., Stefansson K., Magnusson P., Gudmundsson O.O., Gustafsson O., Holmans P., Owen M.J., O'Donovan M., Thapar A. Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet 2010, 376:1401-1408.
160. Xu X., Mill J., Zhou K., Brookes K., Chen C.K., Asherson P. Family-based association study between brain-derived neurotrophic factor gene polymorphisms and attention deficit hyperactivity disorder in UK and Taiwanese samples. American journal of Medical Genetics. Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics 2007, 144B:83-86.
161. Yang B., Chan R.C., Jing J., Li T., Sham P., Chen R.Y. A meta-analysis of association studies between the 10-repeat allele of a VNTR polymorphism in the 3'-UTR of dopamine transporter gene and attention deficit hyperactivity disorder. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics 2007, 144B:541-550.
162. Yang L., Neale B.M., Liu L., Lee S.H., Wray N.R., Ji N., Li H., Qian Q., Wang D., Li J., Faraone S.V., Wang Y., Doyle A.E., Reif A., Rothenberger A., Franke B., Sonuga-Barke E.J., Steinhausen H.C., Buitelaar J.K., Kuntsi J., Biederman J., Lesch K.P., Kent L., Asherson P., Oades R.D., Loo S.K., Nelson S.F., Faraone S.V., Smalley S.L., Banaschewski T., Arias Vasquez A., Todorov A., Charach A., Miranda A., Warnke A., Thapar A., Neale B.M., Cormand B., Freitag C., Mick E., Mulas F., Middleton F., HakonarsonHakonarson H., Palmason H., Schafer H., Roeyers H., McGough J.J., Romanos J., Crosbie J., Meyer J., Ramos-Quiroga J.A., Sergeant J., Elia J., Langely K., Nisenbaum L., Romanos M., Daly M.J., Ribases M., Gill M., O'Donovan M., Owen M., Casas M., Bayes M., Lambregts-Rommelse N., Williams N., Holmans P., Anney R.J., Ebstein R.P., Schachar R., Medland S.E., Ripke S., Walitza S., Nguyen T.T., Renner T.J., Hu X. Polygenic transmission and complex neuro developmental network for attention deficit hyperactivity disorder: genome-wide association study of both common and rare variants. American journal of Medical Genetics. Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics 2013, 162b:419-430.
163. Zhang H., Zhu S., Zhu Y., Chen J., Zhang G., Chang H. An association study between SNAP-25 gene and attention-deficit hyperactivity disorder. European Journal of Paediatric Neurology: Official Journal of the European Paediatric Neurology Society 2011, 15:48-52.
164. Zhang L., Chang S., Li Z., Zhang K., Du Y., Ott J., Wang J. ADHDgene: a genetic database for attention deficit hyperactivity disorder. Nucleic Acids Research 2012, 40:D1003-D1009.
165. Zhou K., Dempfle A., Arcos-Burgos M., Bakker S.C., Banaschewski T., Biederman J., Buitelaar J., Castellanos F.X., Doyle A., Ebstein R.P., Ekholm J., Forabosco P., Franke B., Freitag C., Friedel S., Gill M., Hebebrand J., Hinney A., Jacob C., Lesch K.P., Loo S.K., Lopera F., McCracken J.T., McGough J.J., Meyer J., Mick E., Miranda A., Muenke M., Mulas F., Nelson S.F., Nguyen T.T., Oades R.D., Ogdie M.N., Palacio J.D., Pineda D., Reif A., Renner T.J., Roeyers H., Romanos M., Rothenberger A., Schafer H., Sergeant J., Sinke R.J., Smalley S.L., Sonuga-Barke E., Steinhausen H.C., van der Meulen E., Walitza S., Warnke A., Lewis C.M., Faraone S.V., Asherson P. Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2008, 147B:1392-1398.